Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Structure Reveals How An Enzyme Flips An Antibiotic Chiral Center

Study may someday lead to new antibiotics that better stave off resistance

by Carmen Drahl
March 10, 2014 | A version of this story appeared in Volume 92, Issue 10

[+]Enlarge
Credit: Courtesy of Amie Boal
In the enzyme CarC, tyrosine 165 (transparent purple) is usually disordered, but it locks into place (solid purple) in the presence of a substrate molecule (yellow); iron is green.
This is an X-ray crystal structure of the active site of the enzyme Carbapenem synthase (CarC) with a substrate bound (yellow), active site iron (green), and tyrosine residues (purple).
Credit: Courtesy of Amie Boal
In the enzyme CarC, tyrosine 165 (transparent purple) is usually disordered, but it locks into place (solid purple) in the presence of a substrate molecule (yellow); iron is green.

Carbapenem antibiotics kill diverse bacteria typically without the resistance problems that plague their fellow β-lactam antibiotics. A recent spike in bacterial resistance to carbapenems suggests that may not be true for much longer, however. To make new antibiotics that keep resistance at bay, researchers have been seeking to understand how carbapenems are made in nature. Now, chemists have determined how CarC, an enzyme from microbes that make carbapenems, inverts the stereochemistry at a chiral carbon center crucial for antibiotic activity (Science 2014, DOI: 10.1126/science.1248000). Previous efforts to characterize CarC have been thwarted by the instability of the substrate molecule that the enzyme acts on. Wei-Chen Chang, working in the joint lab of Carsten Krebs and J. Martin Bollinger Jr. at Pennsylvania State University, stabilized the substrate molecule enough to perform a combination of biophysical studies. The stabilization also made possible an X-ray structure, obtained in collaboration with Penn State’s Amie K. Boal and Northwestern University’s Amy C. Rosenzweig. The work indicates that tyrosine 165, an amino acid in the enzyme that’s not visible in prior structures, is essential in the enzyme’s antibiotic-producing mechanism. After an iron(IV)-oxo intermediate abstracts a hydrogen atom from the chiral center, tyrosine 165 donates a hydrogen atom to the opposite face of the substrate molecule, flipping the stereochemistry.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.